Layla Hartsfield-Mosher
Physician Assistant · Phoenix, AZNPI 1437161908
Payments from drug & device makers
Across 384 payments — averaging $29.15 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$2K
- Novo Nordisk$1K
- AstraZeneca$1K
- Bayer$823
- GSK$774
- Medtronic$498
- plus $4K from 32 others
What the payments were for
- Food & beverage$10,88697%
- Education$3083%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 77 | $2,145 |
| Novo Nordisk | 41 | $1,388 |
| AstraZeneca | 43 | $1,352 |
| Bayer | 19 | $823 |
| GSK | 27 | $774 |
| Medtronic | 7 | $498 |
| Amgen | 9 | $364 |
| Nestle Healthcare Nutrition Inc. | 13 | $357 |
| Lilly USA, LLC | 23 | $355 |
| Insulet Corporation | 16 | $335 |
| Sanofi-aventis U.S. LLC | 6 | $317 |
| Pfizer | 14 | $299 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 11 | $275 |
| Astellas Pharma US Inc | 6 | $273 |
| Boehringer Ingelheim | 11 | $261 |
| Biohaven Pharmaceutical Holding Company Ltd. | 7 | $260 |
| Biohaven Pharmaceuticals, Inc. | 6 | $169 |
| Abbott | 8 | $126 |
| Merck | 6 | $95 |
| Dexcom, Inc. | 4 | $90 |
| Sumitomo Pharma America, Inc. | 3 | $80 |
| Aimmune Therapeutics, Inc. | 3 | $72 |
| Boston Scientific | 2 | $63 |
| Amarin Pharma, Inc. | 3 | $41 |
| Xeris Pharmaceuticals, Inc. | 2 | $41 |
| Nevro Corp. | 2 | $36 |
| Mannkind Corporation | 2 | $32 |
| Novartis | 2 | $31 |
| Inspire Medical Systems, Inc. | 1 | $31 |
| Exact Sciences | 2 | $29 |
| Protega Pharmaceutials Inc | 1 | $27 |
| Johnson & Johnson | 1 | $26 |
| Biogen | 1 | $24 |
| Antares Pharma, Inc. | 1 | $23 |
| Eisai Inc. | 1 | $21 |
| Impulse Dynamics (USA) Inc. | 1 | $21 |
| Phathom Pharmaceuticals, Inc. | 1 | $21 |
| Sanofi Pasteur Inc. | 1 | $19 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$11,194 in reported general payments places this provider in the 95th percentile of 2,888 physician assistant providers in Arizona.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 32 | $46,939 |
| JardianceEmpagliflozin | 44 | $32,468 |
| TrulicityDulaglutide | 22 | $30,364 |
| Toujeo SolostarInsulin Glargine,hum.Rec.Anlog | 33 | $28,999 |
| EliquisApixaban | 23 | $24,513 |
| JanuviaSitagliptin Phosphate | 27 | $22,716 |
| MyrbetriqMirabegron | 21 | $22,450 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 31 | $21,341 |
| FarxigaDapagliflozin Propanediol | 26 | $18,691 |
| LinzessLinaclotide | 24 | $15,888 |
| RybelsusSemaglutide | 12 | $13,850 |
| TrintellixVortioxetine Hydrobromide | 14 | $12,095 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 12 | $7,768 |
| Insulin Lispro Kwikpen U-100Insulin Lispro | 22 | $6,432 |
| LantusInsulin Glargine,hum.Rec.Anlog | 43 | $6,161 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic, Rybelsus | $1,388 | $60,78844 claims |
| Boehringer IngelheimJardiance, Tradjenta | $261 | $38,17557 claims |
| Lilly USA, LLCTrulicity | $355 | $30,36422 claims |
| AstraZenecaFarxiga, Breztri Aerosphere | $1,352 | $26,45938 claims |
| PfizerEliquis | $299 | $24,51323 claims |
| MerckJanuvia | $95 | $22,71627 claims |
| Astellas Pharma US IncMyrbetriq | $273 | $22,45021 claims |
| GSKTrelegy Ellipta | $774 | $21,34131 claims |
| AbbVieLinzess | $2,145 | $15,88824 claims |
| Sanofi-aventis U.S. LLCLantus | $317 | $6,16143 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 2,888 physician assistant providers in Arizona.
Other physician assistant in Phoenix
- Alyssa BoschenPhoenix$86K
- Katherine MinorPhoenix$76K
- Micah LasleyPhoenix$52K
- Thomas SirrinePhoenix$37K
- Karla HortonPhoenix$36K
- Larissa AnthonyPhoenix$32K
- Tana FrumentoPhoenix$25K
- Rosemary SrisukPhoenix$17K
- John DorseyPhoenix$17K
- Kendall SmithPhoenix$16K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.